PMC:7534795 / 50352-50637
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T382 | 98-106 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T307 | 83-84 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T308 | 115-120 | http://purl.obolibrary.org/obo/CLO_0007225 | denotes | label |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T32313 | 44-62 | Chemical | denotes | hydroxychloroquine | http://purl.obolibrary.org/obo/CHEBI_5801 |
| T41 | 67-79 | Chemical | denotes | azithromycin | http://purl.obolibrary.org/obo/CHEBI_2955 |
| T73104 | 115-120 | Chemical | denotes | label | http://purl.obolibrary.org/obo/CHEBI_35209 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T417 | 0-285 | Sentence | denotes | Numerous recent studies proposed the use of hydroxychloroquine and azithromycin as a treatment of COVID-19 in open-label non-randomized clinical trials, however, no positive results were produced (Arshad et al., 2020; Cavalcanti, et al., 2020; Gautret et al., 2020; Tang et al., 2020). |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 33031856-32623082-84038900 | 212-216 | 32623082 | denotes | 2020 |
| 33031856-32409561-84038901 | 279-283 | 32409561 | denotes | 2020 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1486 | 44-62 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
| 1487 | 67-79 | Chemical | denotes | azithromycin | MESH:D017963 |
| 1515 | 98-106 | Disease | denotes | COVID-19 | MESH:C000657245 |